DRUG · Unmapped registry intervention
ABM-1310
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors
NCT05501912
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Advanced Solid Tumorunresolved
BRAF V600 Mutationunresolved
Interventions
ABM-1310DRUG
Sponsors & collaborators
ABM Therapeutics Shanghai Company Limitedlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05501912 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.